TREATMENT OF RENAL CELL CARCINOMA BY LENVATINIB AND EVEROLIMUS
- 专利权人:
- 发明人:
- 申请号:
- RU2018134943
- 公开号:
- RU2018134943A3
- 申请日:
- 申请国别(地区):
- RU
- 年份:
- 2020
- 代理人:
- 摘要:
- Methods and compositions for treating a renal cell carcinoma with the combination of lenvatinib or a pharmaceutically acceptable salt thereof and everolimus are provided. Particularly useful dosages and dose modifications upon the occurrence of adverse events are also provided.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- טיפול בקרצינומה של תאי הכליה באמצעות לנווטיניב ואברולימוס
- TREATMENT OF RENAL CELL CARCINOMA WITH LENVATINIB AND EVEROLIMUS
- Treatment of renal cell carcinoma with lenvatinib and everolimus
- METHOD AND COMPOSITIONS FOR PREVENTING STEM CELL DISRUPTION AND AGGREGATION
- EMP2 regulates angiogenesis in cancer cells through induction of VEGF